Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.12.19

Sai Life Sciences Releases Sustainability Report 2025

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the theme “Driving climate action, deepening stakeholder trust.” The full report can be accessed here.

Commenting on the release, Krishna Kanumuri, MD & CEO, Sai Life Sciences, said: “Reliability with responsibility is central to the CRDMO mandate and deeply embedded in how we operate at Sai Life Sciences. Over the past year, we translated this commitment into action through progress across climate actions, circular economy initiatives, people-led HR transformation, and tech-enabled innovation. Going forward, we are focused on scaling these efforts to build a resilient, science-forward, and sustainability-led operating model that delivers enduring value to our partners and stakeholders.”

The report outlines how the company’s sustainability strategy is anchored in nine strategic pillars that collectively guide its approach to responsible growth. These elements span water stewardship, climate action, circularity, biodiversity, sustainable procurement, human capital, governance and ethics, community engagement, and customer co-creation. Together, they constitute a cohesive framework that embeds sustainability priorities into every stage of the company’s operations. By aligning these elements with business objectives and stakeholder expectations, Sai Life Sciences positions sustainability as an intrinsic part of how it innovates, collaborates, and delivers impact.

During the year, the company advanced its internally defined Sustainable Development Goals (SDGs), which outline a clear roadmap for meeting its sustainability commitments by March 31, 2027. The report highlights ongoing progress in greenhouse gas reduction, a significant increase in renewable energy usage—with 96% of the API manufacturing unit in Bidar powered by renewables—and reductions in specific water consumption across facilities. It also documents significant community impact, with the company surpassing its commitment to provide education and livelihood opportunities for 8,000 individuals from underprivileged communities. Strengthening its people agenda, the organisation saw steady growth in diversity, with women representing 14% of the workforce.

The 2024–25 Sustainability Report reflects the company’s long-term view—one that places science, responsibility, and collaboration at the centre of its growth ambition. As Sai Life Sciences continues to expand its global footprint, sustainability remains both a compass and a catalyst for shaping resilient, future-ready operations.

Share article

More News

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more

2026.03.09

AI-enabled production and material planning platform implemented

Over the past several months, focused AI pilot initiatives have been conducted across operations to evaluate practical applications that strengthen execution. One such initiative is now live across the network: Optimus, an integrated AI-enabled production and material planning platform, implemented at the end of December 2025. Optimus consolidates capacity planning, equipment allocation, and material availability […]
Read more

2026.03.09

Commercial-scale Photo Flow Chemistry successfully executed in Bidar

Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations […]
Read more

2026.03.09

High-Throughput Experimentation platform goes live in Hyderabad

The High Throughput Experimentation (HTE) platform is now operational at our Integrated R&D Campus in Hyderabad, India. The system integrates automated experimental execution with structured data capture to support reproducible, high-quality screening and full traceability of results. Designed to evaluate multiple variables within a single experimental matrix, the platform enables rapid assessment of chemical space […]
Read more

2026.02.20

Sai Life Sciences to recruit 700+ professionals in FY27

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professionals during 2026–27 as it scales capabilities to meet growing global demand for end-to-end drug discovery, development and manufacturing services.The recruitment will span roles […]
Read more